Clinical Research Directory
Browse clinical research sites, groups, and studies.
Circulating Activin-A and FSTL3 in Precapillary Pulmonary Hypertension
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
The ACTIOBIO study aims to evaluate the prognostic value of Activin-A and FSTL3 in a large cohort of patients with precapillary pulmonary hypertension, including pulmonary arterial hypertension (Group 1), pulmonary hypertension associated with lung diseases (Group 3), and chronic thromboembolic pulmonary hypertension (Group 4).
Official title: Investigation of Circulating ACTIvin-A and FSTL3 as Prognostic and Predictive BIOmarkers in Precapillary Pulmonary Hypertension
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
550
Start Date
2024-03-01
Completion Date
2028-04
Last Updated
2025-11-28
Healthy Volunteers
No
Conditions
Interventions
Biological collection
Serum, plasma, ADN
Locations (1)
Hôpital Bicêtre (AP-HP.Université Paris-Saclay), Service de Pneumologie et Soins Intensifs
Le Kremlin-Bicêtre, France, France